V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10377566 | 10040386 | 1.8 | 54.3 | Curative (C) | 2017-10-18 | 2017-11-09 | Bortezomib (weekly) | 02 | N | BORTEZOMIB | 100027717 |
| 10377618 | 10040388 | 1.67 | 67 | Adjuvant (A) | 2018-05-01 | 2018-06-10 | Sunitinib | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 101714172 |
| 10377730 | 10040390 | 1.79 | 78 | null | 2019-01-15 | 2019-11-08 | CTD | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101410517 |
| 10377785 | 10040391 | 1.64 | 70.75 | 02 | 2019-02-26 | 2019-03-03 | Cyclophosphamide + Docetaxel | 01 | N | CYTARABINE | 101774586 |
| 10377906 | 10040393 | 1.6 | 77 | Curative (C) | 2018-07-22 | 2018-08-04 | Cisplatin + Vinorelbine (PO) | 02 | null | POMALIDOMIDE | 100447719 |
| 10378046 | 10040395 | 1.78 | 69 | Palliative (P) | 2019-07-30 | 2019-08-15 | Cyclophosphamide + Docetaxel | 02 | N | DARATUMUMAB | 100010228 |
| 10378106 | 10040397 | 0 | 74 | Adjuvant (A) | 2019-07-15 | 2019-08-03 | Busulfan Oral | 02 | N | CAPECITABINE + CISPLATIN | 100228670 |
| 10378145 | 10040399 | 1.77 | 50.2 | Palliative (P) | 2017-06-19 | 2017-06-20 | Gemcitabine + Capecitabine | 02 | null | CISPLATIN + FLUOROURACIL | 100364461 |
| 10378252 | 10040401 | 1.68 | 67.7 | Palliative (P) | 2019-09-06 | 2019-09-07 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101203567 |
| 10378276 | 10040402 | null | null | Palliative (P) | 2015-10-18 | 2019-09-27 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | null | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100452186 |
| 10378436 | 10040406 | 1.65 | 0 | Neo-adjuvant (N) | 2019-07-30 | 2019-08-05 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100628736 |
| 10378627 | 10040408 | 1.46 | 65.1 | Palliative (P) | 2018-11-28 | 2018-12-01 | R Chlorambucil | 02 | N | CHLORAMBUCIL + RITUXIMAB | 100290619 |
| 10378672 | 10040409 | 1.73 | 65 | Palliative (P) | 2021-01-26 | 2021-02-02 | CHOP R | 02 | N | CHOP R | 100006980 |
| 10378725 | 10040410 | 1.7 | 65.5 | 03 | 2015-10-14 | 2015-10-14 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 100017506 |
| 10378730 | 10040411 | 1.6 | 52.1 | 03 | 2017-04-28 | 2017-05-11 | DARATUMUMAB | 02 | N | CAPECITABINE + GEMCITABINE | 101672594 |
| 10378897 | 10040415 | 1.78 | 65.6 | Neo-adjuvant (N) | 2019-02-01 | 2019-02-03 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101008202 |
| 10378936 | 10040416 | null | 68 | Adjuvant (A) | 2019-05-02 | 2019-05-02 | null | 02 | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101238304 |
| 10378984 | 10040418 | 1.73 | 85.1 | Curative (C) | 2021-10-18 | 2021-10-20 | CYCLOPHOSPHAMIDE + RITUXIMAB + Dexamethasone | 99 | null | CYCLOPHOSPHAMIDE + RITUXIMAB | 100528358 |
| 10379044 | 10040420 | 1.77 | 51.3 | 03 | 2019-05-03 | 2019-05-16 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100876909 |
| 10379136 | 10040422 | 1.63 | 68 | null | 2018-01-02 | 2018-01-12 | Temozolomide + RT | 02 | null | TEMOZOLOMIDE | 101684977 |
| 10379189 | 10040423 | 1.74 | null | Adjuvant (A) | 2019-11-12 | 2019-11-30 | Mitomycin Intravesical | 02 | N | MITOMYCIN INTRAVESICULAR | 101192226 |
| 10379328 | 10040424 | 1.72 | 87 | Adjuvant (A) | 2019-06-11 | 2019-06-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101233265 |
| 10379339 | 10040425 | 1.65 | 79.8 | Palliative (P) | 2019-06-12 | 2019-06-15 | CTD | N | N | MITOMYCIN | 100764947 |
| 10379346 | 10040426 | 1.65 | 56.9 | Adjuvant (A) | null | 2018-06-21 | Cyclophosphamide + Docetaxel | N | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 101822681 |
| 10379364 | 10040427 | 1.62 | 68.1 | Neo-adjuvant (N) | 2018-11-03 | 2018-11-10 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 100230973 |
| 10379378 | 10040428 | 1.61 | 54.8 | Palliative (P) | 2020-12-05 | 2020-12-05 | Bortezomib +/- Dexamethasone | 02 | N | BORTEZOMIB | 101041226 |
| 10379416 | 10040429 | 1.76 | 62.9 | Palliative (P) | 2019-07-29 | 2019-08-01 | Acalabrutinib | 02 | N | ACALABRUTINIB | 100096168 |
| 10379427 | 10040431 | 1.52 | 79 | Adjuvant (A) | 2019-03-14 | 2019-03-23 | Sunitinib | 02 | N | CVP R | 100525588 |
| 10379463 | 10040433 | 1.66 | 73 | null | 2016-11-28 | 2016-11-30 | CYTARABINE | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100825168 |
| 10379510 | 10040435 | 1.81 | 82.1 | null | 2021-08-19 | 2021-09-06 | CVP R | 02 | null | SUNITINIB | 100250244 |
| 10379553 | 10040437 | 1.63 | 64.7 | null | 2019-04-04 | 2019-04-05 | Mitomycin Intravesical | N | N | MITOMYCIN INTRAVESICULAR | 100504168 |
| 10379584 | 10040438 | 1.75 | 111 | Adjuvant (A) | 2019-12-03 | 2019-12-18 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | N | Y | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 100292640 |
| 10379717 | 10040442 | 1.66 | 59.5 | Curative (C) | 2017-12-20 | 2018-01-03 | R Chlorambucil | 02 | null | CHLORAMBUCIL + RITUXIMAB | 100925496 |
| 10379734 | 10040443 | 1.78 | 41.6 | null | 2022-03-18 | 2022-03-18 | Palbociclib | 02 | null | PALBOCICLIB | 100411424 |
| 10379774 | 10040445 | 1.46 | 72 | Curative (C) | 2019-01-22 | 2019-05-02 | FEC 100 | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101333127 |
| 10379803 | 10040446 | 1.6 | 46.5 | 03 | 2018-08-30 | 2018-09-04 | BUSULFAN | N | N | CVP R | 101266607 |
| 10379842 | 10040447 | 1.71 | 74.3 | Adjuvant (A) | 2017-05-01 | 2017-06-21 | MITOMYCIN | 02 | N | CAPECITABINE + CISPLATIN | 100530464 |
| 10379860 | 10040449 | 1.65 | 61.35 | 03 | 2018-04-19 | 2018-04-20 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101317522 |
| 10379974 | 10040450 | 1.73 | 80 | Palliative (P) | 2019-09-25 | 2019-09-26 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100578824 |
| 10380023 | 10040453 | 1.8 | 53.8 | null | 2021-06-17 | 2022-02-28 | Avelumab | 02 | null | AVELUMAB | 100643928 |
| 10380090 | 10040454 | 1.75 | 98 | Curative (C) | 2019-12-18 | 2019-12-30 | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 02 | N | DOCETAXEL + FLUOROURACIL + OXALIPLATIN | 100496821 |
| 10380115 | 10040455 | 1.55 | 78.3 | 02 | 2020-10-30 | 2020-11-21 | MITOMYCIN | 1 | N | PAZOPANIB | 101327336 |
| 10380131 | 10040456 | null | null | null | 2017-11-28 | 2017-12-05 | Bortezomib +/- Dexamethasone | null | null | BORTEZOMIB | 100894482 |
| 10380173 | 10040457 | 1.69 | 91.2 | Palliative (P) | 2017-01-21 | 2017-01-21 | CHOP R - 21 days | 2 | N | CHOP R | 100661968 |
| 10380223 | 10040458 | 1.68 | 83 | 03 | 2016-12-25 | 2017-01-01 | EOX | 02 | Y | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101186980 |
| 10380249 | 10040459 | 1.68 | 49 | Neo-adjuvant (N) | 2016-03-02 | 2016-03-09 | Pazopanib | 02 | N | DARATUMUMAB | 101290899 |
| 10380310 | 10040460 | 1.8 | 106.8 | 03 | 2019-04-30 | 2019-05-01 | FLUOROURACIL + IRINOTECAN | 02 | N | FLUOROURACIL + IRINOTECAN | 101737939 |
| 10380491 | 10040463 | 0 | 90 | null | 2021-12-30 | 2021-12-30 | CVP R | 02 | null | BUSULFAN | 100357870 |
| 10380513 | 10040464 | 1.76 | 71 | 03 | 2016-09-23 | 2016-10-02 | Cytarabine Low Dose | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101129962 |
| 10380547 | 10040465 | 1.72 | 95.2 | Curative (C) | 2019-08-18 | 2019-08-21 | DARATUMUMAB | 02 | N | CARBOPLATIN + PEMBROLIZUMAB + PEMETREXED | 100992871 |